The Prognostic Value of Tumor Size, Volume and Tumor Volume Reduction Rate During Concurrent Chemoradiotherapy in Patients With Cervical Cancer
Open Access
- 14 July 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 934110
Abstract
Objective: This study aimed to investigate the relationship between prognostic and tumor parameters of cervical cancer patients, such as tumor size (TS), tumor volume (TV), and tumor volume reduction rate (TVRR) after external beam radiotherapy.Methods: A total of 217 patients with advanced cervical cancer, classified as Federation of Gynecology and Obstetrics (FIGO) IIa–IVa, were enrolled in the study. Pre- and mid-RT pelvic magnetic resonance imaging (MRI) were performed twice, during RT and just before brachytherapy.Results: The median follow-up time was 51 months (range, 7–111 months). The 5-year overall survival (OS), progression-free survival (PFS), and local failure-free survival (LFFS) rates were 81.3, 85.1, and 92.9%, respectively. Multivariate analysis revealed that tumor parameters including FIGO stage >II (Hazard Ratio, 2.377 and 95% confidence interval [CI], 1.091–5.182; P = 0.029), pre-RT TV >61.6 cm3 (HR, 0.417 and 95% CI, 0.188–0.926; P = 0.032), and mid-RT TV >11.38 cm3 (HR, 3.192 and 95% CI, 1.094–9.316; P = 0.034) were observably associated with OS. Univariate analysis showed that the tumor volume reduction rate (TVRR) was dramatically associated with overall survival (HR, 0.204 and 95% CI 0.033–1.282; P <0.001) and local failure-free survival (P = 0.050).Conclusions: In this retrospective study, TVRR and mid-radiotherapy tumor volume are independent and strong prognostic parameters for patients with local advanced cervical cancer receiving CCRT.Keywords
This publication has 36 references indexed in Scilit:
- Outcomes of Chemoradiotherapy in Cervical Cancer—The Western Australian ExperienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Prognostic implications of tumor volume response and COX-2 expression change during radiotherapy in cervical cancer patientsRadiation Oncology Journal, 2012
- Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancerGynecologic Oncology, 2011
- The prognostic significance of tumor volume regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI☆Gynecologic Oncology, 2007
- Multimodality Therapy for Locally Advanced Cervical Carcinoma: State of the Art and Future DirectionsJournal of Clinical Oncology, 2007
- Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective studyInternational Journal of Gynecological Cancer, 2007
- Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinomaGynecologic Oncology, 2006
- p73 Expression Is Associated with the Cellular Radiosensitivity in Cervical Cancer after RadiotherapyClinical Cancer Research, 2004
- Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical CancerNew England Journal of Medicine, 1999
- Correlation of squamous cell carcinoma antigen levels and treatment response in cervical cancerGynecologic Oncology, 1991